097459128	097459128	CD	B-NP	O
|	|	NN	I-NP	O
GH	GH	NN	I-NP	O
|	|	NN	I-NP	O
09309168	09309168	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0920369	0920369	CD	B-NP	O
|	|	CC	I-NP	O
8/8/2005	8/8/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PNEUMONIA	PNEUMONIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/28/2005	3/28/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
ARONHALT	ARONHALT	NN	B-NP	O
,	,	,	O	O
ODIS	ODIS	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Sandy	Sandy	NNP	B-NP	O
Jefferson	Jefferson	NNP	I-NP	O
Malan	Malan	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

COPD	COPD	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Arrhythmia	Arrhythmia	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

AVNRT/SVT	AVNRT/SVT	NN	B-NP	O
.	.	.	O	O

CHIEF	CHIEF	NN	B-NP	B-protein
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
arrhythmias	arrhythmia	NNS	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
but	but	CC	O	O
returned	return	VBD	B-VP	O
later	later	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
complaining	complaining	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
fevers	fever	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
prior	prior	JJ	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
presented	present	VBN	I-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
and	and	CC	I-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
minor	minor	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	O	O
nebulizer	nebulizer	NN	B-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
antibiotics	antibiotic	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
home	home	NN	I-NP	O
O2	O2	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
presentation	presentation	NN	B-NP	O
on	on	IN	B-PP	O
9/30/05	9/30/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
oxygen	oxygen	NN	I-NP	O
needs	need	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
102.4	102.4	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
left	leave	VBN	I-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
from	from	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
PECT	PECT	NN	I-NP	B-protein
on	on	IN	B-PP	O
4/19/05	4/19/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
9/30/05	9/30/05	CD	B-NP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirements	requirement	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Past	Past	NNP	B-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a.	a.	NN	B-NP	O
fib	fib	NN	I-NP	O
with	with	IN	B-PP	O
SVT	SVT	NN	B-NP	O
not	not	RB	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
controlled	control	VBN	B-VP	O
on	on	IN	B-PP	O
diet	diet	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
,	,	,	O	O
Hytrin	Hytrin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Flovent	Flovent	NNP	B-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Atrovent	Atrovent	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
allergies	allergy	NNS	B-NP	O
to	to	TO	B-PP	O
sulfa	sulfa	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
quinine	quinine	NN	B-NP	O
causing	cause	VBG	B-VP	O
platelet	platelet	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
quit	quit	VBN	I-VP	O
cigarette	cigarette	NN	B-NP	O
and	and	CC	O	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
illicit	illicit	JJ	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
95/53	95/53	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
96	96	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
crackles	crackle	NNS	B-NP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
side	side	NN	I-NP	O
being	be	VBG	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
right	right	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
exam	exam	NN	I-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
,	,	,	I-NP	O
murmurs	murmur	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurologically	Neurologically	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
labs	lab	NNS	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
ABG	ABG	NN	I-NP	O
with	with	IN	B-PP	O
pH	pH	NN	B-NP	O
of	of	IN	B-PP	O
7.42	7.42	CD	B-NP	O
,	,	,	O	O
PaCO2	PaCO2	NN	B-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
,	,	,	O	O
PaO2	PaO2	NN	B-NP	O
of	of	IN	B-PP	O
52	52	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V2-V3	V2-V3	NN	B-NP	O
,	,	,	O	O
flat	flat	JJ	B-NP	O
V4	V4	NN	I-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
first-degree	first-degree	JJ	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
assessment	assessment	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
recently	recently	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
for	for	IN	B-PP	O
minor	minor	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
flare	flare	NN	I-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
hypoxemia	hypoxemia	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
with	with	IN	B-PP	O
COPD	COPD	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
a.	a.	NN	B-NP	O
Hypoxia	Hypoxia	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
required	require	VBD	B-VP	O
short	short	JJ	B-NP	O
term	term	NN	I-NP	O
MICU	MICU	NN	I-NP	O
stay	stay	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
BiPAP	BiPAP	NN	I-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	I-VP	O
facemask	facemask	VB	I-VP	O
over	over	IN	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
two	two	CD	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
8	8	CD	B-NP	O
liters	liter	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
where	where	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
management	management	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/4/05	10/4/05	CD	B-NP	O
,	,	,	O	O
day	day	NN	B-NP	O
3	3	CD	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
liters	liter	NNS	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
coughing	cough	VBG	I-VP	O
and	and	CC	O	O
abruptly	abruptly	RB	B-VP	O
desaturated	desaturate	VBN	I-VP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
nonrebreather	nonrebreather	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
on	on	IN	B-PP	O
9/30/05	9/30/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
DuoNeb	DuoNeb	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
stabilized	stabilize	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
managed	manage	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
8	8	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
weaned	wean	VBN	I-VP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
91-97	91-97	CD	B-NP	O
%	%	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
desaturate	desaturate	VB	I-VP	O
with	with	IN	B-PP	O
activities	activity	NNS	B-NP	O
and	and	CC	O	O
requires	require	VBZ	B-VP	O
further	further	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
including	include	VBG	B-PP	O
chest	chest	NN	B-NP	O
PT	PT	NN	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
mucus	mucus	NN	B-NP	O
plugging	plug	VBG	B-VP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
PE	PE	NN	I-NP	I-protein
from	from	IN	B-PP	O
earlier	early	JJR	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
in	in	IN	B-PP	O
April	April	NNP	B-NP	O
.	.	.	O	O

b.	b.	RB	B-ADVP	O
Pneumonia	Pneumonia	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
azithromycin	azithromycin	NN	B-NP	O
on	on	IN	B-PP	O
9/30/05	9/30/05	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sputum	sputum	NN	I-NP	O
culture	culture	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
briefly	briefly	NN	B-NP	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
from	from	IN	B-PP	O
8/14/05	8/14/05	CD	B-NP	O
to	to	TO	B-PP	O
08	08	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
with	with	IN	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
and	and	CC	I-NP	O
azithromycin	azithromycin	NN	I-NP	O
on	on	IN	B-PP	O
5/26/05	5/26/05	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
leaving	leave	VBG	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
two	two	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
10-day	10-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

c.	c.	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
most	most	RBS	I-VP	O
recently	recently	RB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
5/10/05	5/10/05	CD	B-NP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
DuoNeb	DuoNeb	NN	B-NP	O
and	and	CC	I-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
DuoNeb	DuoNeb	NNP	B-NP	O
treatments	treatment	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
course	course	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
performed	perform	VBD	B-VP	O
but	but	CC	O	O
with	with	IN	B-PP	O
benefit	benefit	NN	B-NP	O
from	from	IN	B-PP	O
PFT	PFT	NN	B-NP	O
studies	study	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
tapered	taper	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

d.	d.	JJ	B-NP	O
Hypertension	Hypertension	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
but	but	CC	B-PP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
that	that	WDT	B-NP	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
98	98	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Insmotho	Insmotho	NNP	I-NP	O
Erout	Erout	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Service	Service	NNP	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Malv	Malv	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Service	Service	NNP	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
need	need	VB	I-VP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
function	function	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
around	around	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
9/30/05	9/30/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
initially	initially	RB	B-ADVP	O
had	have	VBD	B-VP	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
held	hold	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	B-DNA
increasing	increase	VBG	I-NP	O
edema	edema	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
aggressively	aggressively	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
still	still	RB	B-ADVP	O
has	have	VBZ	B-VP	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
remained	remain	VBN	I-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.1-1	1.1-1	CD	B-NP	O
.2	.2	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
Lasix	Lasix	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
although	although	IN	B-SBAR	O
he	he	PRP	B-NP	O
required	require	VBD	B-VP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
on	on	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
occasions	occasion	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

b.	b.	JJ	B-NP	O
Hypertension	Hypertension	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
from	from	IN	B-PP	O
110-130s	110-130	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
regarding	regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

c.	c.	NN	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
biomarkers	biomarker	NNS	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
statin	statin	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

d.	d.	RB	B-ADVP	O
Rate	Rate	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
arrhythmias	arrhythmia	NNS	B-NP	O
with	with	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
SVTs	SVT	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
last	last	JJ	B-NP	O
admission	admission	NN	I-NP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
in	in	IN	B-PP	O
SVT	SVT	NN	B-NP	O
and	and	CC	O	O
hypotensive	hypotensive	JJ	B-ADJP	O
and	and	CC	O	O
reverted	revert	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
DuoNeb	DuoNeb	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
occasionally	occasionally	RB	I-VP	O
have	have	VB	I-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
140s	140	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
AV	AV	NN	B-NP	O
nodal	nodal	JJ	I-NP	O
reentry	reentry	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
incidences	incidence	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
last	last	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
general	general	JJ	B-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
although	although	IN	B-ADVP	O
did	do	VBD	B-VP	O
occasionally	occasionally	RB	B-ADVP	O
did	do	VBD	B-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
occasion	occasion	NN	B-NP	O
during	during	IN	B-PP	O
these	these	DT	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
arrhythmia	arrhythmia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
under	under	IN	B-PP	O
diet	diet	NN	B-NP	O
control	control	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
with	with	IN	B-PP	O
steroid	steroid	NN	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
COPD	COPD	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
measured	measure	VBN	B-VP	O
regularly	regularly	RB	B-ADVP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
a	a	DT	B-NP	O
regular	regular	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
steroid-induced	steroid-induced	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
tapering	taper	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
has	have	VBZ	B-VP	O
generally	generally	RB	I-VP	O
ranged	range	VBN	I-VP	O
between	between	IN	B-PP	O
100-150	100-150	CD	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
required	require	VBN	I-VP	O
less	less	JJR	B-NP	O
insulin	insulin	NN	I-NP	B-protein
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
glucose	glucose	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	I-NP	O
cover	cover	NN	I-NP	O
with	with	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
discuss	discuss	VBP	B-VP	O
further	further	RBR	B-ADVP	O
his	his	PRP$	B-NP	O
overall	overall	JJ	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
around	around	IN	B-PP	O
1.1-1	1.1-1	CD	B-NP	O
.2	.2	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
initial	initial	JJ	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
1.7	1.7	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Lasix	Lasix	NNP	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
Lasix	Lasix	NNP	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
closely	closely	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
diureses	diurese	VBZ	B-VP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
did	do	VBD	B-VP	O
rise	rise	VB	I-VP	O
slowly	slowly	RB	B-ADVP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
diureses	diures	NNS	B-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
outweighed	outweigh	VBD	B-VP	O
his	his	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
During	During	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	O	O
repleted	replete	VBN	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
regarding	regard	VBG	B-VP	O
his	his	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
or	or	CC	O	O
nutritional	nutritional	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
low-salt	low-salt	JJ	B-NP	O
2	2	CD	I-NP	O
g	g	NN	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
limit	limit	NN	B-VP	O
his	his	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	VB	B-VP	O
to	to	TO	B-PP	O
1.5	1.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
initial	initial	JJ	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
101.2	101.2	CD	B-NP	O
with	with	IN	B-PP	O
white	white	JJ	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
as	as	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
as	as	IN	B-PP	O
16	16	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
as	as	IN	B-SBAR	O
dictated	dictate	VBN	B-VP	O
above	above	RB	B-ADVP	O
in	in	IN	B-PP	O
pulmonary	pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	RB	B-ADVP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	B-cell_line
therapy	therapy	NN	I-NP	I-cell_line
his	his	PRP$	B-NP	I-cell_line
sputum	sputum	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
10-day	10-day	JJ	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
white	white	JJ	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
12.6	12.6	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
slightly	slightly	VB	I-VP	O
his	his	PRP$	B-NP	O
overall	overall	JJ	I-NP	O
white	white	JJ	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
production	production	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
regular	regular	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
deferred	defer	VBD	B-VP	O
bowel	bowel	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
proton	proton	NN	B-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
and	and	CC	O	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

PROPHYLAXIS	PROPHYLAXIS	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
CODE	CODE	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-VP	O
rehab	rehab	VB	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
includes	include	VBZ	B-VP	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
for	for	IN	B-PP	O
headaches	headache	NNS	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
Humulin	Humulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
a.c.	a.c.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
if	if	IN	B-SBAR	O
pulse	pulse	NN	B-NP	O
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
are	be	VBP	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
110	110	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

x2	x2	CD	B-NP	O
doses	dose	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Hytrin	Hytrin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
IV	IV	CD	B-NP	O
daily	daily	RB	B-ADVP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Levaquin	Levaquin	NNP	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
at	at	IN	B-PP	O
3/0	3/0	CD	B-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
levalbuterol	levalbuterol	NN	B-NP	O
1.25	1.25	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
albuterol	albuterol	NN	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
2h	2h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	NN	B-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
cautioning	caution	VBG	I-NP	O
using	use	VBG	I-NP	O
albuterol	albuterol	NN	I-NP	O
in	in	IN	B-PP	O
patient	patient	NN	B-NP	O
given	give	VBN	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
SVT	SVT	NN	B-NP	O
after	after	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENT	APPOINTMENT	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Herbst	Herbst	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
Lesports	Lesports	NNP	B-NP	O
Bouldbrighmegris	Bouldbrighmegris	NNP	I-NP	O
Green	Green	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
10/21/05	10/21/05	CD	I-NP	O
at	at	IN	B-PP	O
9.40	9.40	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hammans	Hammans	NNP	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
1/29/05	1/29/05	CD	B-NP	O
at	at	IN	B-PP	O
10.40	10.40	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
contact	contact	VB	I-VP	O
the	the	DT	B-NP	O
Erni	Erni	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Service	Service	NNP	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
his	his	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
to	to	TO	B-VP	O
reach	reach	VB	I-VP	O
him	him	PRP	B-NP	O
is	be	VBZ	B-VP	O
by	by	IN	B-PP	O
765-284-8509	765-284-8509	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-1243056	4-1243056	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Berry	Berry	NNP	B-NP	O
Andres	Andres	NNP	I-NP	O
Bruson	Bruson	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Sterhasschister	Sterhasschister	NNP	I-NP	O
Noo	Noo	NNP	I-NP	O
Rie	Rie	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Hubert	Hubert	NNP	B-NP	O
Darou	Darou	NNP	I-NP	O
MD	MD	NNP	I-NP	O
Lene	Lene	NNP	I-NP	O
Ale	Ale	NNP	I-NP	O
Co	Co	NNP	I-NP	O
Arv	Arv	NNP	I-NP	O
Ey	Ey	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MCPHERREN	MCPHERREN	NNP	B-NP	O
,	,	,	O	O
SILAS	SILAS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOVELOCK	LOVELOCK	NNP	B-NP	O
,	,	,	O	O
GRAHAM	GRAHAM	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1586969	1586969	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/21/05	2/21/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/21/05	2/21/05	CD	B-NP	O

